David R. Luke

2.4k total citations
87 papers, 1.9k citations indexed

About

David R. Luke is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, David R. Luke has authored 87 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 17 papers in Infectious Diseases and 15 papers in Epidemiology. Recurrent topics in David R. Luke's work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Renal Transplantation Outcomes and Treatments (10 papers) and Pharmacological Effects and Toxicity Studies (10 papers). David R. Luke is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (17 papers), Renal Transplantation Outcomes and Treatments (10 papers) and Pharmacological Effects and Toxicity Studies (10 papers). David R. Luke collaborates with scholars based in United States, United Kingdom and Australia. David R. Luke's co-authors include Kiumars Vadiei, John Trinder, George Foulds, G. Lopez‐Berestein, Helen J. Burgess, Young Jin Kim, Konrad E. Tomaszewski, Bharat Damle, Lane J. Brunner and Haran T. Schlamm and has published in prestigious journals such as The Journal of Immunology, Clinical Infectious Diseases and Kidney International.

In The Last Decade

David R. Luke

84 papers receiving 1.8k citations

Peers

David R. Luke
Robert A. Blum United States
Stéphane Mouly France
John H. Cavanaugh United States
William G. Kramer United States
Walter K. Kraft United States
Seo Hyun Yoon South Korea
Daniel M. Canafax United States
Elaine Radwanski United States
Sylvie Saivin France
J. B. Fourtillan France
Robert A. Blum United States
David R. Luke
Citations per year, relative to David R. Luke David R. Luke (= 1×) peers Robert A. Blum

Countries citing papers authored by David R. Luke

Since Specialization
Citations

This map shows the geographic impact of David R. Luke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Luke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Luke more than expected).

Fields of papers citing papers by David R. Luke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Luke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Luke. The network helps show where David R. Luke may publish in the future.

Co-authorship network of co-authors of David R. Luke

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Luke. A scholar is included among the top collaborators of David R. Luke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Luke. David R. Luke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hoover, Randall, Harry Alcorn, Laura Lawrence, et al.. (2018). Clinical Pharmacokinetics of Sulfobutylether‐β‐Cyclodextrin in Patients With Varying Degrees of Renal Impairment. The Journal of Clinical Pharmacology. 58(6). 814–822. 27 indexed citations
3.
Luke, David R., et al.. (2011). Temporal changes in ROTEM®-measured coagulability of citrated blood samples from coagulopathic trauma patients. Injury. 44(1). 36–39. 9 indexed citations
4.
Ng, Khai Ping, M. Ferring, David R. Luke, & Stephen A. Smith. (2009). Pericatheter herniation complicated by bowel incarceration in a patient on continuous ambulatory peritoneal dialysis (CAPD). Clinical Nephrology. 71(2). 221–223. 4 indexed citations
5.
Luke, David R.. (1999). Alatrofloxacin Versus Cefotetan in Prophylaxis of Colorectal Surgery. Drugs. 58(Supplement 2). 286–287. 1 indexed citations
6.
Luke, David R.. (1999). Oral Trovafloxacin Versus Intravenous Cefoxitin in Elective Hysterectomy. Drugs. 58(Supplement 2). 284–285. 1 indexed citations
7.
8.
9.
Berens, Kurt L., Regina Verani, & David R. Luke. (1998). Role of Neutrophils and Macrophages in Experimental Nephrosis of the Rat. Renal Failure. 20(1). 53–63. 7 indexed citations
10.
Luke, David R., et al.. (1993). Influence of Pentoxifylline on Renal Function in HIV-Scropositive Patients. Renal Failure. 15(2). 181–188. 4 indexed citations
11.
Luke, David R.. (1992). Immunosuppressive effect of cyclosporine in the hyperlipidemic rat model. Biopharmaceutics & Drug Disposition. 13(9). 635–645. 8 indexed citations
12.
Luke, David R. & Kurt L. Berens. (1992). Effects of Suprofen on the Isolated Perfused Rat Kidney. Renal Failure. 14(2). 187–192. 1 indexed citations
13.
Luke, David R., Kishor M. Wasan, Regina Verani, et al.. (1991). Attenuation of Amphotericin-B Nephrotoxicity in the Candidiasis Rat Model. ˜The œNephron journals/Nephron journals. 59(1). 139–144. 8 indexed citations
14.
Luke, David R.. (1991). Effects of the immune system on cyclosporine absorption. Xenobiotica. 21(6). 817–824. 1 indexed citations
15.
Luke, David R., Kishor M. Wasan, Teresa McQueen, & Gabriel Lopez‐Berestein. (1990). Enhancement of the Treatment of Experimental Candidiasis with Vascular Decongestants. The Journal of Infectious Diseases. 162(1). 211–214. 12 indexed citations
16.
Berens, Kurt L., Kiumars Vadiei, Lane J. Brunner, Kishor M. Wasan, & David R. Luke. (1990). Influence of lovastatin on the pharmacokinetics, toxicity and immunologic response of cyclosporine in the obese zucker rat. Biopharmaceutics & Drug Disposition. 11(3). 197–206. 5 indexed citations
17.
Luke, David R., Kurt L. Berens, & Regina Verani. (1989). Role of Vascular Decongestion in Ischemic Acute Renal Failure Defined by Postinsult Administration of Pentoxifylline. Renal Failure. 11(4). 187–194. 13 indexed citations
18.
Vadiei, Kiumars, Lane J. Brunner, & David R. Luke. (1989). Effects of pentoxifylline in experimental acute renal failure. Kidney International. 36(3). 466–470. 31 indexed citations
19.
Brunner, Lane J., et al.. (1989). Cyclosporine pharmacokinetics and effect in the Type I diabetic rat model. European Journal of Drug Metabolism and Pharmacokinetics. 14(4). 287–292. 6 indexed citations
20.
Luke, David R.. (1952). Advertisements in the Post-bag. BMJ. 2(4785). 670.2–670. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert A. Blum Breakdown of academic impact, for papers by Stéphane Mouly Breakdown of academic impact, for papers by John H. Cavanaugh Breakdown of academic impact, for papers by William G. Kramer Breakdown of academic impact, for papers by Walter K. Kraft Breakdown of academic impact, for papers by Seo Hyun Yoon Breakdown of academic impact, for papers by Daniel M. Canafax Breakdown of academic impact, for papers by Elaine Radwanski Breakdown of academic impact, for papers by Sylvie Saivin Breakdown of academic impact, for papers by J. B. Fourtillan
Rankless by CCL
2026